EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma

Jinghua Lu, Yipei Ding, Wanqiu Zhang, Yuanyuan Qi, Jin Zhou iD, Naihan Xu, Yaou Zhang iD, Weidong Xie iD

Cells · 2023

DOI: 10.3390/cells12091238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Jinghua Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Sequestosome-1 Protein. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Science and Technology Program, State Key Laboratory of Chemical Oncogenomics Shenzhen International Graduate School, Tsinghua University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Migration and invasion play crucial roles in the progression of hepatocellular carcinoma (HCC), but the underlying mechanisms are not clear. Analysis of clinical samples indicates that SQSTM1/p62 is highly expressed in HCC and seriously affects the prognosis of patients. Subsequently, we showed that SQSTM1/p62 knockout using the CRISPR/Cas9 system led to impaired migration and invasion of HCC, upregulated Keap1, and promoted the inhibitory effect of Keap1 on Nrf2. Then, the inactivation of Nrf2 inhibited the expression of matrix metalloproteinases (MMPs), thus attenuating the migration and invasion of HCC. We also found that SQSTM1/p62 knockout significantly inhibited migration and invasion in a lung metastasis model of nude mice with HCC. Furthermore, we found that cisplatin not only significantly inhibited the expression of SQSTM1/p62 but also slowed down the migration and invasion of HCC, while the inflammatory microenvironment accelerated the migration and invasion of HCC. These results suggest for the first time that SQSTM1/p62 knockout inhibits the migration and invasion of HCC through the Keap1/Nrf2/MMP2 signaling pathway. SQSTM1/p62 may be developed into a key drug target to regulate the migration and invasion of HCC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsSequestosome-1 ProteinAnimalsMiceCRISPR-Cas SystemsKelch-Like ECH-Associated Protein 1Mice, KnockoutMice, NudeNF-E2-Related Factor 2Tumor MicroenvironmentHumans

Stichwörter der Autor:innen

SQSTM1/p62hepatocellular carcinomainvasionmigration

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Sequestosome-1 ProteinSqstm1 protein, mouseSQSTM1 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Chemical Oncogenomics, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
  • Shenzhen Key Laboratory of Health Science and Technology, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.
  • Institute for Ocean Engineering, Shenzhen International Graduate School, Tsinghua University, Shenzhen 518055, China.

ORCID-Profile: Jin Zhou, Yaou Zhang, Weidong Xie

Förderung

  • Shenzhen Science and Technology Program
  • State Key Laboratory of Chemical Oncogenomics Shenzhen International Graduate School, Tsinghua University

Zitieren

APA

Lu, J., Ding, Y., Zhang, W., Qi, Y., Zhou, J., Xu, N., Zhang, Y., & Xie, W. (2023). SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells. https://doi.org/10.3390/cells12091238

Vancouver

Lu J, Ding Y, Zhang W, Qi Y, Zhou J, Xu N, et al. SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma. Cells. 2023. doi:10.3390/cells12091238

BibTeX
@article{Lu2023,
  author = {Lu, Jinghua and Ding, Yipei and Zhang, Wanqiu and Qi, Yuanyuan and Zhou, Jin and Xu, Naihan and Zhang, Yaou and Xie, Weidong},
  title = {SQSTM1/p62 Knockout by Using the CRISPR/Cas9 System Inhibits Migration and Invasion of Hepatocellular Carcinoma},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12091238}
}
Kostenlos starten →